Michael G Grey's Net Worth
$33.5 Million
Who is Michael G Grey?
Michael G Grey has an estimated net worth of $33.5 Million. This is based on reported shares across multiple companies, which include Horizon Therapeutics Public Ltd Co, SGX PHARMACEUTICALS, INC., BIOMARIN PHARMACEUTICAL INC, Mirati Therapeutics, Inc., Mirum Pharmaceuticals, Inc., Reneo Pharmaceuticals, Inc., SPRUCE BIOSCIENCES, INC., ACHILLION PHARMACEUTICALS INC, and IDM PHARMA, INC..
SEC CIK
Michael G Grey's CIK is 0001240122
Past Insider Trading and Trends
2020 was Michael G Grey's most active year for acquiring shares with 13 total transactions. Michael G Grey's most active month to acquire stocks was the month of April. 2008 was Michael G Grey's most active year for disposing of shares, totalling 48 transactions. Michael G Grey's most active month to dispose stocks was the month of February. 2012 saw Michael G Grey paying a total of $1,568,385.00 for 107,165 shares, this is the most they've acquired in one year. In 2023 Michael G Grey cashed out on 357,923 shares for a total of $12,646,280.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Horizon Therapeutics Public Ltd Co No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -97.39K |
$116.50 | -$11,346,168.00 |
0
|
Oct 6
| |||
Form 4
| +103.30% | 20K |
$15.96 | $319,200.00 | 39.36K |
Sep 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 27
| |||
Form 4
| +25.33% | 3.91K |
—
|
—
| 19.36K |
Apr 28
| |||
Form 4
| +4.95% | 3.08K |
$98.56 | -$112,259.84 | 65.37K |
Apr 28 - Apr 29
| |||
Form 4
|
—
|
0
|
$51.21 | -$488,350.00 |
0
|
Scheduled
|
Jul 22
| ||
Form 4
| +13.01% | 8.11K |
$94.62 | -$283,197.66 | 70.39K |
Apr 29 - Apr 30
| |||
Form 4
|
—
|
0
|
$46.33 | -$1,318,650.00 |
0
|
Scheduled
|
Apr 12
| ||
Form 4
|
—
|
0
|
$38.65 | -$121,797.00 |
0
|
Scheduled
|
Aug 5
| ||
Form 4
|
—
|
0
|
$31.98 | -$98,367.75 |
0
|
Scheduled
|
Jul 22
| ||
Form 4
|
—
|
0
|
$29.48 | -$89,592.75 |
0
|
Scheduled
|
Jun 25
| ||
Form 4
|
—
|
0
|
$28.31 | -$430,949.73 |
0
|
May 22
| |||
Form 4
| +32.81% | 15.39K |
—
|
—
| 62.29K |
Apr 30 - May 2
| |||
Form 4
| +31.33% | 11.19K |
$26.54 | -$109,663.28 | 46.9K |
May 2 - May 3
| |||
Form 4
| +40.33% | 10.26K |
$13.87 | -$52,567.30 | 35.71K |
May 3
| |||
Form 4
| +64.73% | 10K |
$9.48 | $94,800.00 | 25.45K |
May 10
| |||
Form 4
| +193.80% | 10.19K |
$15.12 | -$56,896.56 | 15.45K |
May 3
| |||
Form 4
|
∞
| 5.26K |
—
|
—
| 5.26K |
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 29
| |||
| No matching records found | |||||||||
SGX PHARMACEUTICALS, INC. No price found
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -100.00K |
$3.00 | -$300,000.00 |
0
|
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIOMARIN PHARMACEUTICAL INC (BMRN) Snapshot price: $89.7377
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$51.39 | -$248,950.00 | 42.84K |
Mar 5
| |||
Form 4
|
—
|
0
|
$73.42 | -$234,650.00 | 42.84K |
Scheduled
|
Aug 3
| ||
Form 4
| +11.16% | 4.3K |
—
|
—
| 42.84K |
May 27
| |||
Form 4
| +12.99% | 4.43K |
—
|
—
| 38.54K |
Jun 4
| |||
Form 4
| +14.42% | 4.3K |
—
|
—
| 34.11K |
Jun 5
| |||
Form 4
| +7.38% | 2.05K |
—
|
—
| 29.81K |
Jun 6
| |||
Form 4
| +5.75% | 1.51K |
—
|
—
| 27.76K |
Jun 6
| |||
Form 4
|
—
|
0
|
$59.30 | -$310,575.00 | 26.25K |
Scheduled
|
Feb 22
| ||
Form 4
|
—
|
0
|
$71.43 | -$492,628.50 | 26.25K |
Scheduled
|
Nov 16
| ||
Form 4
| +4.37% | 1.1K |
—
|
—
| 26.25K |
Jun 10
| |||
Form 4
| +9.11% | 2.1K |
—
|
—
| 25.15K |
Jun 4 - Jun 6
| |||
Form 4
|
—
|
0
|
$45.69 | -$1,438,380.00 | 23.05K |
Dec 11
| |||
Form 4
| +17.30% | 3.4K |
—
|
—
| 23.05K |
May 15
| |||
Form 4
|
—
|
0
|
$37.50 | -$693,285.00 | 19.65K |
Mar 3 - Mar 6
| |||
Form 4
| +20.92% | 3.4K |
—
|
—
| 19.65K |
May 8
| |||
Form 4
| +369.23% | 60K |
$26.14 | $1,568,385.00 | 16.25K |
Feb 23
| |||
Form 4
| +18.18% | 2.5K |
—
|
—
| 16.25K |
May 12
| |||
Form 4
| +22.22% | 2.5K |
—
|
—
| 13.75K |
May 12
| |||
Form 4
| +28.57% | 2.5K |
—
|
—
| 11.25K |
May 22
| |||
Form 4
| +40.00% | 2.5K |
—
|
—
| 8.75K |
May 12
| |||
Form 4
| +25.00% | 1.25K |
—
|
—
| 6.25K |
Jul 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
| -41.18% | -3.50K |
$38.41 | -$134,446.00 | 5K |
Mar 5
| |||
Form 4
|
∞
| 8.5K |
$24.25 | -$510,781.51 | 8.5K |
Mar 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Mirati Therapeutics, Inc. (MRTX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +34.66% | 1.48K |
—
|
—
| 5.73K |
Jan 15
| |||
Form 4
|
—
|
0
|
$131.14 | -$2,491,789.24 | 4.26K |
Scheduled
|
Dec 14
| ||
Form 4
| +88.65% | 2K |
—
|
—
| 4.26K |
Jan 3
| |||
Form 4
| +25.47% | 458 |
$59.64 | -$252,682.48 | 2.26K |
Scheduled
|
Nov 12
| ||
Form 4
| +34.18% | 458 |
$54.56 | -$221,756.55 | 1.8K |
Scheduled
|
Aug 12
| ||
Form 4
|
∞
| 1.34K |
$41.07 | -$256,574.10 | 1.34K |
Scheduled
|
May 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Mirum Pharmaceuticals, Inc. (MIRM) Snapshot price: $26.815
Executive Chairman
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
$17.47 | -$424,566.91 |
0
|
Sep 13 - Sep 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
$15.97 | -$380,742.91 |
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
$15.47 | -$366,134.91 |
0
|
May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
| +2.83% | 7.95K |
—
|
—
| 289.2K |
Jul 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||